SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001214659-23-016097
Filing Date
2023-12-06
Accepted
2023-12-06 17:01:41
Documents
1
Period of Report
2023-11-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-63722.html 4/A  
1 PRIMARY DOCUMENT marketforms-63722.xml 4/A 16070
  Complete submission text file 0001214659-23-016097.txt   17431
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Krogulski Kenneth (Reporting) CIK: 0001695580 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33637 | Film No.: 231470365